Kyntra Bio KYNB
NASDAQ KYNB
$5.21 -0.14 (-2.70%)
As of: Oct 21, 2026 · 11:26 AM EDT

Kyntra Bio (KYNB) Debt Ratio (2023 - 2026)

Updated

Kyntra Bio's (KYNB) Debt Ratio stood at 0.41 in Q2 2025, up 67.5% from 0.25 a year earlier but down 6.8% from the prior quarter.

Analysis

Kyntra Bio (KYNB) Debt Ratio (2023 - 2026) Analysis & Trends

For FY2024, Kyntra Bio's Debt Ratio came in at 0.34, up 100.6% from FY2023.

  • Across earlier years, Debt Ratio came in at 0.17 in FY2023.
  • Quarterly Debt Ratio has ranged from 0.14 in Q2 2023 to 0.44 in Q1 2025 over the past five years.
  • On a year-over-year basis, Debt Ratio has increased for five consecutive quarters, with growth averaging 89.7% over the last five quarters.
  • Per Business Quant, the preceding three quarters came in at 0.44 (Q1 2025), 0.34 (Q4 2024) and 0.28 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 0.24
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 0.52
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 0.42
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 0.08
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.28
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 0.53
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 0.31
10 Kyntra Bio 21.09 Mn -386.85 Mn 1.47 Mn 0.19
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.19
Jun 30, 2025 0.41
Mar 31, 2025 0.44
Dec 31, 2024 0.34
Sep 30, 2024 0.28
Jun 30, 2024 0.25
Mar 31, 2024 0.20
Dec 31, 2023 0.17
Sep 30, 2023 0.16
Jun 30, 2023 0.14
API Access

Kyntra Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=KYNB&period=max&api_key=YOUR_API_KEY